Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MNI Nutraceuticals, also known as the Medical Nutritional Institute, is a South African healthcare company dedicated to developing research-based nutraceuticals and lifestyle intervention programs. The company focuses on addressing prevalent non-communicable diseases such as metabolic syndrome, insulin resistance, and chronic inflammation through non-prescription pharmacological solutions. Their flagship products include Antagolin for blood sugar regulation, RyChol for cholesterol management, and NeuroVance for cognitive support and stress relief. MNI distinguishes itself by emphasizing clinical evidence and holistic health strategies, often pairing their supplements with structured lifestyle assessments to improve long-term patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MNI Nutraceuticals.